Type 2 diabetes mellitus (T2DM) associated non-alcoholic fatty liver disease (NAFLD) is the
fourth-leading cause of death. Hyperglycemia induces various complications, including …

The gut microbiota is an ecosystem including all bacterial species that permanently colonize
the gastro intestinal tract and a large number of other microorganisms from the environment …

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease which affects≈
25% of the adult population worldwide, placing a tremendous burden on human health. The …

In recent years, the incidence of non-viral hepatocellular carcinoma (HCC) has increased
dramatically, which is probably related to the increased prevalence of metabolic syndrome …

Fructose is one of the key dietary catalysts in the development of non-alcoholic fatty liver
disease (NAFLD). NAFLD comprises a complex disease spectrum, including steatosis (fatty …

Mushrooms have long been used for medicinal and food purposes for over a thousand
years, but a complete elucidation of the health-promoting properties of mushrooms through …

With a long history in traditional Asian medicine, Ganoderma lucidum (G. lucidum) is a
mushroom species suggested to improve health and extend life. Its medicinal reputation has …

Nonalcoholic fatty liver disease (NAFLD) is a major cause of chronic liver disease and it
encompasses a spectrum from simple steatosis to steatohepatitis, fibrosis, or cirrhosis. The …

Low‐level of chronic inflammation activation is characteristic of obesity. Nonalcoholic fatty
liver disease (NAFLD) is closely linked to obesity and is an emerging health problem, it …

Precision medicine defines the attempt to identify the most effective approaches for specific
subsets of patients based on their genetic background, clinical features, and environmental …